Behçet's disease from the aspect of autoinflammatory disease

Japanese Journal of Clinical Immunology

Volumn 34, Issue 5, 2011, Pages 408-419

  Ishigatsubo, Yoshiaki ^a   Samukawa, Sei ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Autoinflammatory disease; Beh et's disease; Familial mediterranean fever; MEFV; Th17

Indexed keywords

COLCHICINE; HLA B51 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STREPTOCOCCUS ANTIGEN;

ARTICLE; AUTOINFLAMMATORY DISEASE; BEHCET DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; ENVIRONMENTAL FACTOR; FAMILIAL MEDITERRANEAN FEVER; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENITAL ULCER; HUMAN; IMMUNOREACTIVITY; LEUKOCYTE ACTIVATION; MEFV GENE; NEUTROPHIL; PATHOGENESIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; SKIN MANIFESTATION; SOUTHERN EUROPE; STOMATITIS; TH1 CELL; TH17 CELL; UVEITIS;

AUTOIMMUNITY; BEHCET SYNDROME; CYTOSKELETAL PROTEINS; DRUG DESIGN; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEREDITARY AUTOINFLAMMATORY DISEASES; HLA-B51 ANTIGEN; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; MOLECULAR TARGETED THERAPY; MUTATION; TH17 CELLS;

EID: 80455173643     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.34.408     Document Type: Article

References (59)

1. Japanese Sources
2. Japanese Sources
3. Ben-Chetrit E. et al.: Familial mediterranean fever and Behçet's disease-are they associated? J Rheumatol 29: 530-534, 2002.
4. Yoshida A. et al.: Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology 111: 810-815, 2004.
5. M. C. Mat et al.: Mucocutaneous Manifestations and Pathergy Reaction in Behçet's Disease. Yusuf Yazi̇ci̇, Hasan Yazi̇ci̇, Behçet's Syndrome, 1, Springer, New York, 53-72, 2010.
6. Arnson Y. et al.: Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34: J258-65, 2010.
7. Scully C. et al.: Auto-inflammatory syndromes and oral health. Oral Dis 14: 690-699, 2008.
8. Braun-Falco M. et al.: Skin manifestations in autoinflammatory syndromes. J Dtsch Dermatol Ges 9: 232-246, 2011.
9. Japanese Sources
10. Raiji VR. et al. : Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene. J AAPOS 15; 205-207, 2011.
11. Terrada C. et al.: Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra. J Ophthalmic Inflamm Infect in press, 2011.
12. Gül A. et al.: Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4: 81-83, 2005.
13. Lindor NM. et al.: A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72.: 611-615, 1997.
14. Sakane T. et al.: Behçet's disease. N Engl J Med 341: 1284-91, 1999.
15. Ideguchi H et al.: Behçet Disease Evolution of Clinical Manifestations. Medicine 90: 125-132, 2011.
16. van der Hilst JC. et al.: Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine 87: 301-310, 2008.
17. Larsen S. et al.: Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 42: 97-114, 2010.
18. Japanese Sources
19. Bakkaloglu A.: Familial Mediterranean fever. Pediatr Nephrol 18: 853-859, 2003.
20. Ideguchi H. et al.: Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J Neurol. 257: 1012-20, 2010.
21. Akman-Demir G. et al.: Interleukin-6 in neuro-Behçet's disease: association with disease subsets and long-term outcome. Cytokine 44: 373-376, 2008.
22. Japanese Sources
23. Kotake et al.: Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology 106: 586-589, 1999.
24. Japanese Sources
25. Japanese Sources
26. Yahalom G. et al.: Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol in press 2011.
27. Direskeneli H.: Autoimmunity vs autoinflammation in Behçet's disease: do we oversimplify a complex disorder? Rheumatology 45: 1461-1465, 2006.
28. Menthon M. et al.: HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 61: 1287-1296, 2009.
29. Yasuoka H. et al.: Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. Arthritis Rheum 50: 3658-3662, 2004.
30. Kaneko F. et al.: The role of streptococcal hypersensitivity in the pathogenesis of Behçet's Disease. Eur J Dermatol 18: 489-498, 2008.
31. Direskeneli H. et al.: The role of heat shock proteins in Behçet's disease. Clin Exp Rheumatol 21: S44-8, 2003.
32. Hirohata S. et al.: Streptococcal antigens stimulate production of IL-6 and interferon-γ by cells from patients with behcet's diseas. Cell Immunol 140: 410-419, 1992.
33. Yokota K. et al.: Antibody response to oral streptococci in Behçet's disease. Microbiol Immunol 36: 815-822, 1992.
34. Matsuda M. et al.: Coexistence of familial Mediterranean fever and Behçet's disease in a Japanese patient. Intern Med 45: 799-800, 2006.
35. Seyahi E. et al.: The prevalence of Behçet's syndrome, familial Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians living in Istanbul, Turkey. Clin Exp Rheumatol 28: S67-75, 2010.
36. Ayesh S. et al.: Molecular analysis of MEFV gene mutations among Palestinian patients with Behçet's disease. Scand J Rheumatol 37: 370-374, 2008.
37. Rabinovich E. et al.: Common FMF alleles may predispose to development of Behçet's disease with increased risk for venous thrombosis. Scand J Rheumatol 36: 48-52, 2007.
38. Dursun A. et al.: Genetic analysis of MEFV gene pyrin domain in patients with Behçet's disease. Mediators Inflamm 2006: 41783, 2006.
39. Imirzalioglu N. et al.: MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rheumatol 34: 56-58, 2005.
40. Atagunduz P. et al.: MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 21: S35-7, 2003.
41. Aksu K. et al.: coexistence of vasculitides with Familial Mediterranean Fever. Rheumatol Int in press, 2011.
42. Marek-Yagel D. et al.: Is E148Q a benign polymorphism or a disease-causing mutation? J Rheumatol 36: 2372, 2009.
43. Migita K. et al.: MEFV mutations in Japanese rheumatoid arthritis patients. Clin Exp Rheumatol 26: 1091-1094, 2008.
44. Gul A.: Selective pressures for the high prevalence of MEFV variants induced by smallpox infection in the "Old World": A hypothesis. Clin Exp Rheumatol 24: 213, 2006.
45. Masters SL. et al.: Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27: 621-668, 2009.
46. Scully C. et al.: Immunoglobulins G, M, A, D and E in Behçet's syndrome. Clin Chim Acta 120: 237-242, 1982.
47. Japanese Sources
48. Duzgun N. et al.: Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease. Rheumatol Int. 25: 1-5, 2005.
49. Bilginer Y. et al.: Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease. Clin Rheumatol 29: 209-210, 2009.
50. Botsios C. et al.: Resistant Behçet disease responsive to anakinra. Ann Intern Med 149: 284-286, 2008.
51. Deal watch: XOMA and Servier to develop anti-IL-1β antibody for inflammatory diseases. Nat Rev Drug Discov 10: 166, 2011.
52. Chae JJ. et al.: Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146: 467-478, 2009.
53. Miossec P. et al.: Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888-898, 2009.
54. Leng RX. et al.: The role of IL-23/IL-17 axis in the etiopathogenesis of Behçet's disease. Clin Rheumatol 29: 1209, 2010.
55. Arayssi T. et al.: New insights into the pathogenesis and therapy of Behçet's sisease. Curr Opin Pharmacol 17: 183-188, 2004
56. Mizuki N. et al.: Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet 42: 703-706, 2010.
57. Lasiglie D. et al.: Role of IL-1 beta in the development of human T (H) 17 cells: lesson from NLPR3 mutated patients. PLoS One in press, 2011.
58. Tada Y. et al.: The association of Behçet's disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol 24: S115-9, 2006.
59. Fujimura T. et al.: Periodic fever and erythema nodosum associated with MDS with trisomy 8: report of two cases and review of the literature. Mod Rheumatol 20: 413-419, 2010.